Simulations Plus (SLP) has put up a mixed Q2 2026 scorecard, with revenue of about US$24.3 million and basic EPS of roughly US$0.22, alongside trailing twelve month figures that show total revenue of about US$80.5 million and a basic EPS loss of roughly US$3.12. Over recent quarters, revenue has ranged from about US$17.5 million to US$24.3 million while quarterly basic EPS has swung between a loss of about US$3.35 and a profit of roughly US$0.22. This leaves investors focused squarely on how much of that top line is translating into sustainable margins and a path back to consistent profitability.

See our full analysis for Simulations Plus.

With the latest numbers on the table, the next step is to see how this earnings profile lines up with the most common narratives around Simulations Plus and where those storylines may need to be updated.

TTM losses contrast with recent quarterly profit

• Q2 2026 showed net income of about US$4.5 million and basic EPS of roughly US$0.22, but the trailing twelve months still reflect a net loss of about US$62.8 million and a basic EPS loss of roughly US$3.12.
• Bears focus on the reported 65.4% per year decline in earnings over the last five years and argue that the recent profitable quarters do not yet offset the scale of trailing losses.
  • The TTM loss of about US$62.8 million lines up with that longer term earnings decline, while only two of the last six quarters show basic EPS above zero.
  • This pattern fits the cautious view that margin pressure and acquisition related issues, including the US$77.2 million non cash impairment mentioned in the bearish narrative, have kept overall profitability weak even as individual quarters turn a profit.

Skeptics point out that a stock can show improving quarterly profits and still have a deep trailing loss hanging over it, which is exactly the setup bearish analysts focus on for Simulations Plus. 🐻 Simulations Plus Bear Case

Revenue growth steady but not high

• Trailing twelve month revenue is about US$80.5 million, growing at roughly 5.1% per year, which is below the cited 10.5% per year growth rate for the broader US market.
• The bullish view expects higher growth from AI powered software and new clinical trial verticals, and the current 5.1% revenue growth rate gives a mixed read on that optimism.
  • Bulls highlight strong QSP performance and cross selling opportunities, while the last six quarters show revenue moving between about US$17.5 million and US$24.3 million per quarter, which keeps growth modest on a trailing basis.
  • This combination supports the idea that new offerings could matter over time, but the present revenue run rate does not yet reflect the higher growth path assumed in the bullish projections.

When bulls talk about AI tools and new verticals changing the story, it is worth lining those claims up against the current 5.1% revenue growth to see how much is already visible in the reported numbers. 🐂 Simulations Plus Bull Case

Valuation signals pull in opposite directions

• At a share price of US$13.04, Simulations Plus trades below a cited DCF fair value of about US$22.55, while its P/S of 3.3x sits above the US Healthcare Services average of 2.1x and a peer average of 1.5x.
• Analysts' consensus narrative points out that investors are weighing this mix of a discount to DCF fair value and a premium P/S multiple against the company being unprofitable on a trailing basis.
  • Supporters of the consensus view can point to the gap between US$13.04 and the DCF fair value of about US$22.55 as potential upside, balanced by the reality that TTM earnings are still a loss and the P/S multiple is higher than sector and peer levels.
  • This tension means the case for the stock rests on how readers judge the trade off between current losses and the expectations baked into the analyst price target of about US$23.67.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Simulations Plus on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With mixed signals on growth, profitability and valuation, the real question is how you weigh the trade off between risk and potential reward. Take a closer look at the full picture for yourself and see the 1 key reward and 1 important warning sign.

See What Else Is Out There

Simulations Plus currently faces a trailing twelve month loss of about US$62.8 million and modest 5.1% revenue growth, alongside higher P/S multiples than sector peers.

If that mix of ongoing losses and only moderate growth feels like a stretch for your risk comfort, check out the 72 resilient stocks with low risk scores to quickly focus on companies with more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.